Monday Swings MEGL .89-5.87 JZXN .13-.31 AGBA 1.64-5.37 MWG 2.01-7.99 TPST 1.72-3.80 Long Plays META CVX LMT EDIT OWL APCX Become A Member Contact [email protected] Receive Daily Swings..Day Trades..Buy and Holds..Alerts Throughout The Day
Monday Swings ATSG 14.83-20.92 MINM 2.00-8.18 Long Plays GSAT EDIT OCUP TVTX Become A Member Receive Daily Plays [email protected]
CELC Biotech focuses on development of molecular therapies for cancer patients Yesterday announced positive updated results from Phase 1 study of Gedatolisib in treatment-naive patients at the 2023 ESMO Breast Cancer Annual Congress Become a Member Daily Listings and Alerts throughout The Day Contact:[email protected]
RCKT Healthcare Developes gene therapies.. Presented positive data from LV Hematology and AAV Cardiovascular Gene Therapy ETNR,,Lead Drug Candidate focuses on Liver and Cardio-Metabolic Diseases VIRX..Oncology..Developes Drugs for Treatment of Virus-Associated Malignancies MORF..Biopharma..Developes oral small-molecule therapeutics for treatment of Autoimmune..Cardiovascular..Metabolic diseases as well as Fibrosis and Cancers Become A Member Of Our Group Early Morning Lists..Alerts Throughout The Day [email protected]
DTN Treats Muscle Disease AKBA Therapeutics For Kidney Disease PL Aerospace and Defense GD Aerospace and Defense ENPH Solar Become a Group Member Early Morning Listings Alerts Throughout The Day [email protected]
ALDX Upside...Biotech Lead Drug Candidate..Treats Eye Disease MNPR Upside...Biopharma Developes Therapeutics To Treat Cancer GMDA Upside Developes Cell Therapies To Cure Blood Cancers and Serious Blood Diseases Lead Drug Candidate GDA`201 Ongoing Phase1/2Clinical Trial for Non`Hodgkins Lymphoma Autl Upside..Biopharma Developes T`Cell Therapy for the Treatment of Cancer Last Week Announced Positive Results from their Phase 2 Study of Drug Candidate Felix for Treatment of Acute Lymphoblastic Leukemia Become a Member Receive Early Morning Listings..Daily Alerts Throughout The Day [email protected]
